Article
The TRAIL apoptotic pathway in cancer onset, progression and therapy.
Nature reviews. Cancer - 1 Oct 2008
Johnstone Ricky W, Frew Ailsa J, Smyth Mark J
Abstract excerpt
Triggering of tumour cell apoptosis is the foundation of many cancer therapies. Death receptors of the tumour necrosis factor (TNF) superfamily have been largely characterized, as have the signals that are generated when these receptors are activated. TNF-related apoptosis-inducing ligand (TRAIL) receptors (TRAILR1 and TRAILR2) are promising targets for cancer therapy. Herein we review what is known about the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
